| 【英語論文】 |
| |
原著論文 |
| |
|
1. Kawamura K, Ikeda T, Hagiwara S, Mori T, Shinagawa A, Nishiwaki K, Ohashi K, Kubonishi S, Fukuda T, Ito T, Tomita N, Ichinohe T, Kato K, Morishima Y, Atsuta Y, Sunami K and Kanda Y: Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis. Leukemia and Lymphoma. 2016; 9: 1-7. |
| |
|
2. Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Ogawa Y, Shimizu T, Otsuka M, Matsumoto M, Iida S, Terui Y, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A and Chou T: Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: a phase II study. Cancer Science. 2016; 107: 653-658. |
| |
|
3. Nakasu Y, Mitsuya K, Hayashi N, Okamura I, Mori K, Ito I, Tatara R, Nakasu S and Ikeda T: Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma, a long-term monocenter retrospective study. SpringerPlus. 2016; 307: 1954-1956. |
| |
|
4. Muroi K, Miyamura K, Okada M, Yamashita T, Murata M, Ishikawa T, Uike N, Hidaka M, Kobayashi R, Imamura M, Tanaka J, Ohashi K, Taniguchi S, Ikeda T, Eto T, Mori M, Yamaoka M and Ozawa K: Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. International Journal of Hematology. 2016; 103: 243-250. |
| |
症例報告 |
| |
|
1. Okamura-Shiki I, Tatara R and Ikeda T: Paraneoplastic refractory prurigos in a Hodgkin lymphoma patient. Japanese Journal of Clinical Oncology. 2016; 46: 1179-1180. |
| |
|
2. Okamura-Shiki I, Nakamura Y, Katsurada Y, Sato K, Ikeda T and Kimura F: Successful Corticosteroid Treatment for Purpura Fulminans Associated with Quinolone. Internal Medicine. 2016; 55: 3047-3051. |
| |
Letter等 |
| |
|
1. Okamura-Shiki I and Ikeda T: Epstein-Barr virus associated with a lymphoma-mimicking lesion of the uterine cervix. BLOOD 2016; 128: 1439. |
